Mobile

A Phase II, double-blind, randomized, cross-over, international, multicentre study to evaluate the analgesic efficacy of 3 weeks oral administration of AZD4282 300 mg b.i.d. compared with placebo in p...

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-004908-21

A Phase II, double-blind, randomized, cross-over, international, multicentre study to evaluate the analgesic efficacy of 3 weeks oral administration of AZD4282 300 mg b.i.d. compared with placebo in postherpetic neuralgia

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the analgesic efficacy of 3 weeks oral administration of AZD4282 compared with placebo in postherpetic neuralgia.

Critère d'inclusion

  • Diagnosis of postherpetic neuralgia

Liens